Skip to Content
Merck
  • Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole.

Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology (2011-03-25)
Rola Hussein, Mustapha El-Halabi, Ola Ghaith, Nawaf Jurdi, Cecilio Azar, Nabil Mansour, Ala I Sharara
ABSTRACT

Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially - available combination of two antibiotics - spiramycin and metronidazole - commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Spiramycin
Spiramycin, European Pharmacopoeia (EP) Reference Standard
Supelco
Spiramycin from Streptomyces sp., VETRANAL®, analytical standard, mixture of isomers